In this photo illustration, a Snapchat logo seen displayed on a smartphone. (Photo Illustration by Mateusz Slodkowski/SOPA Images/LightRocket via Getty Images)
Chatbot, meet Snapchat. Snap, the company behind the popular video sharing platform, is launching a chatbot called My AI that uses the latest version of OpenAI's ChatGPT.
"My AI can recommend birthday gift ideas for your BFF, plan a hiking trip for a long weekend, suggest a recipe for dinner, or even write a haiku about cheese for your cheddar-obsessed pal," Snap wrote in a blog post announcing the feature.
Yet Snap also made sure to mention that AI-powered chatbots are "prone to hallucination and can be tricked into saying just about anything."
"Please be aware of its many deficiencies and sorry in advance! All conversations with My AI will be stored and may be reviewed to improve the product experience. Please do not share any secrets with My AI and do not rely on it for advice."
The company added that, "while My AI is designed to avoid biased, incorrect, harmful, or misleading information, mistakes may occur. Please press and hold on any message from My AI to submit feedback."
The feature will be available to Snapchat+ subscribers starting this week.
Smoke that filled the cabin of a Delta flight as it took off from the Atlanta airport in February was so thick the led flight attendant had trouble seeing past the first row of passengers and the pilots donned oxygen masks as a precaution.
Arjan Stephens, President of Nature's Path, discusses the company's origin, how it has evolved today and the interesting product that came from his wedding!
Small business reporter, Gene Marks, joins Cheddar to give analysis on how small businesses are tackling incoming tariffs and how it will affect the consumer.
Babylist CEO Natalie Gordon joins Cheddar to discuss how the website is helping new parents, how to make a registry and how secondhand options are available.
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.